KR102522067B1 - 무-세포 메틸화된 dna의 포획 방법 및 이의 이용 - Google Patents

무-세포 메틸화된 dna의 포획 방법 및 이의 이용 Download PDF

Info

Publication number
KR102522067B1
KR102522067B1 KR1020217023549A KR20217023549A KR102522067B1 KR 102522067 B1 KR102522067 B1 KR 102522067B1 KR 1020217023549 A KR1020217023549 A KR 1020217023549A KR 20217023549 A KR20217023549 A KR 20217023549A KR 102522067 B1 KR102522067 B1 KR 102522067B1
Authority
KR
South Korea
Prior art keywords
dna
nucleic acid
sample
acid molecules
filler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217023549A
Other languages
English (en)
Korean (ko)
Other versions
KR20210095962A (ko
Inventor
드 까르발로 다니엘 디니즈
슈 이 센
라자트 싱하니아
Original Assignee
유니버시티 헬스 네트워크
시나이 헬스 시스템
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 헬스 네트워크, 시나이 헬스 시스템 filed Critical 유니버시티 헬스 네트워크
Priority to KR1020237012338A priority Critical patent/KR20230054746A/ko
Publication of KR20210095962A publication Critical patent/KR20210095962A/ko
Application granted granted Critical
Publication of KR102522067B1 publication Critical patent/KR102522067B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1093General methods of preparing gene libraries, not provided for in other subgroups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2522/00Reaction characterised by the use of non-enzymatic proteins
    • C12Q2522/10Nucleic acid binding proteins
    • C12Q2522/101Single or double stranded nucleic acid binding proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/186Modifications characterised by incorporating a non-extendable or blocking moiety
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/164Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
KR1020217023549A 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용 Active KR102522067B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020237012338A KR20230054746A (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662331070P 2016-05-03 2016-05-03
US62/331,070 2016-05-03
KR1020187034995A KR102359767B1 (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
PCT/CA2017/000108 WO2017190215A1 (en) 2016-05-03 2017-05-03 Methods of capturing cell-free methylated dna and uses of same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020187034995A Division KR102359767B1 (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020237012338A Division KR20230054746A (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용

Publications (2)

Publication Number Publication Date
KR20210095962A KR20210095962A (ko) 2021-08-03
KR102522067B1 true KR102522067B1 (ko) 2023-04-13

Family

ID=60202577

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020217023549A Active KR102522067B1 (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
KR1020237012338A Ceased KR20230054746A (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
KR1020187034995A Active KR102359767B1 (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020237012338A Ceased KR20230054746A (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
KR1020187034995A Active KR102359767B1 (ko) 2016-05-03 2017-05-03 무-세포 메틸화된 dna의 포획 방법 및 이의 이용

Country Status (7)

Country Link
US (5) US11078475B2 (https=)
EP (2) EP4425178A3 (https=)
JP (3) JP6979554B2 (https=)
KR (3) KR102522067B1 (https=)
CN (1) CN109415763A (https=)
BR (1) BR112018072536A2 (https=)
WO (1) WO2017190215A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9115386B2 (en) 2008-09-26 2015-08-25 Children's Medical Center Corporation Selective oxidation of 5-methylcytosine by TET-family proteins
KR102522067B1 (ko) * 2016-05-03 2023-04-13 유니버시티 헬스 네트워크 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
MX2019007444A (es) 2016-12-22 2019-08-16 Guardant Health Inc Metodos y sistemas para analisis de moleculas de acido nucleico.
CA3063405A1 (en) * 2017-05-12 2018-11-15 President And Fellows Of Harvard College Universal early cancer diagnostics
US12227737B2 (en) * 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
BR112020000681A2 (pt) * 2017-07-12 2020-07-14 University Health Network detecção e classificação de cancro utilizando análise de metilome
US20210156863A1 (en) * 2017-11-03 2021-05-27 University Health Network Cancer detection, classification, prognostication, therapy prediction and therapy monitoring using methylome analysis
CN108796057A (zh) * 2018-06-29 2018-11-13 上海交通大学 一种少量样品全基因组dna甲基化的检测方法及试剂盒
CN108796039B (zh) * 2018-06-29 2021-10-08 上海交通大学 一种用于dna甲基化检测的试剂盒与方法及应用
CN109023537B (zh) * 2018-09-04 2021-10-08 上海交通大学 一种微量dna样品高通量测序文库的构建技术
CN109097439A (zh) * 2018-09-04 2018-12-28 上海交通大学 一种检测少量样品全基因组dna甲基化的方法
WO2020160414A1 (en) * 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
CN109825559A (zh) * 2019-03-11 2019-05-31 上海交通大学 一种血浆cfDNA全局性甲基化检测方法及应用
US11891653B2 (en) 2019-09-30 2024-02-06 Guardant Health, Inc. Compositions and methods for analyzing cell-free DNA in methylation partitioning assays
CN115087744A (zh) * 2019-11-06 2022-09-20 大学健康网络 用于无细胞MeDIP测序的合成加标对照及其使用方法
EP4617375A3 (en) * 2019-11-26 2025-10-29 Guardant Health, Inc. Methods, compositions and systems for improving the binding of methylated polynucleotides
CN111154846A (zh) * 2020-01-13 2020-05-15 四川大学华西医院 一种甲基化核酸的检测方法
EP4715052A2 (en) * 2020-05-18 2026-03-25 Myriad Women's Health, Inc. Nucleic acid sample enrichment and screening methods
US12592321B2 (en) 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
KR102332540B1 (ko) 2020-07-02 2021-11-29 의료법인 성광의료재단 다운증후군 특이적인 후성학적 마커를 이용한 다운증후군 진단 방법
KR102332539B1 (ko) 2020-07-02 2021-11-29 의료법인 성광의료재단 다운증후군 진단용 후성학적 바이오마커 조성물 및 이의 용도
EP4585697A3 (en) * 2020-07-30 2025-08-06 Guardant Health, Inc. Methods for isolating cell-free dna
AU2021345359A1 (en) 2020-09-21 2023-05-11 Enumera Molecular, Inc. Compositions and methods for isolation of cell-free dna
EP4222278A1 (en) * 2020-09-30 2023-08-09 Guardant Health, Inc. Compositions and methods for analyzing dna using partitioning and a methylation-dependent nuclease
JP2023547620A (ja) 2020-10-23 2023-11-13 ガーダント ヘルス, インコーポレイテッド 分配および塩基変換を使用してdnaを解析するための組成物および方法
JP2024525190A (ja) * 2021-06-18 2024-07-10 シングレラ ジェノミクス (チャンスー) リミテッド 腫瘍評価のための物質及び方法
JP2024523401A (ja) * 2021-06-21 2024-06-28 ガーダント ヘルス, インコーポレイテッド コピー数情報に基づく組織起源分析のための方法および組成物
CN113621691A (zh) * 2021-09-27 2021-11-09 广东省妇幼保健院 基于一代测序技术直接检测KLF1基因启动子区CpG甲基化的方法和试剂盒
CN114045342A (zh) * 2021-12-01 2022-02-15 大连晶泰生物技术有限公司 一种游离DNA(cfDNA)甲基化突变的检测方法及试剂盒
WO2023107709A1 (en) * 2021-12-10 2023-06-15 Adela, Inc. Methods and systems for generating sequencing libraries
WO2023192635A2 (en) * 2022-04-01 2023-10-05 Twist Bioscience Corporation Libraries for methylation analysis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017514499A (ja) 2014-05-09 2017-06-08 ライフコーデックス アーゲー 特別な細胞タイプに由来するdnaの検出とそれに関連する方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818762B2 (en) * 2001-05-25 2004-11-16 Maine Molecular Quality Controls, Inc. Compositions and methods relating to nucleic acid reference standards
AU2002363062B2 (en) * 2001-10-09 2007-03-22 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
CN101802223A (zh) * 2007-08-15 2010-08-11 香港大学 用于高通量亚硫酸氢盐dna-测序的方法和组合物及其用途
CN103443338B (zh) * 2011-02-02 2017-09-22 华盛顿大学商业化中心 大规模平行邻接作图
US8895249B2 (en) * 2012-06-15 2014-11-25 Illumina, Inc. Kinetic exclusion amplification of nucleic acid libraries
US9732390B2 (en) * 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
SI4056712T1 (sl) * 2012-09-20 2024-10-30 The Chinese University Of Hong Kong Neinvazivno določanje metiloma tumorja iz plazme
US10706957B2 (en) * 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
TWI813141B (zh) * 2014-07-18 2023-08-21 香港中文大學 Dna混合物中之組織甲基化模式分析
KR102522067B1 (ko) * 2016-05-03 2023-04-13 유니버시티 헬스 네트워크 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
BR112020000681A2 (pt) * 2017-07-12 2020-07-14 University Health Network detecção e classificação de cancro utilizando análise de metilome
US20210156863A1 (en) * 2017-11-03 2021-05-27 University Health Network Cancer detection, classification, prognostication, therapy prediction and therapy monitoring using methylome analysis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017514499A (ja) 2014-05-09 2017-06-08 ライフコーデックス アーゲー 特別な細胞タイプに由来するdnaの検出とそれに関連する方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
nature protocols, 2012, Vol.7, No.4, pp.617-636 1부.*

Also Published As

Publication number Publication date
US11560558B2 (en) 2023-01-24
US20220119796A1 (en) 2022-04-21
US20220073902A1 (en) 2022-03-10
BR112018072536A2 (pt) 2019-03-26
US20230287384A1 (en) 2023-09-14
EP4425178A2 (en) 2024-09-04
JP7434215B2 (ja) 2024-02-20
JP2021168657A (ja) 2021-10-28
KR20210095962A (ko) 2021-08-03
JP2019521315A (ja) 2019-07-25
EP3452615A1 (en) 2019-03-13
CA3022606A1 (en) 2017-11-09
EP3452615A4 (en) 2019-12-04
US20250313825A1 (en) 2025-10-09
CN109415763A (zh) 2019-03-01
KR20190003987A (ko) 2019-01-10
US20190144848A1 (en) 2019-05-16
JP2024054242A (ja) 2024-04-16
WO2017190215A1 (en) 2017-11-09
US11078475B2 (en) 2021-08-03
KR102359767B1 (ko) 2022-02-08
KR20230054746A (ko) 2023-04-25
JP6979554B2 (ja) 2021-12-15
EP4425178A3 (en) 2024-12-18

Similar Documents

Publication Publication Date Title
KR102522067B1 (ko) 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
JP7256748B2 (ja) エラーが訂正された核酸配列決定への適用を伴う標的化核酸配列濃縮のための方法
CN113661249B (zh) 用于分离无细胞dna的组合物和方法
JP2023139162A (ja) メチローム解析を用いる癌の検出及び分類
US20190256924A1 (en) Methods and materials for assessing and treating cancer
Kwon et al. Genome-wide analysis of DNA methylation and the gene expression change in lung cancer
US20220243263A1 (en) Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
CN114616343A (zh) 用于在甲基化分区测定中分析无细胞dna的组合物和方法
US20220205050A1 (en) Method and markers for identifying and quantifying of nucleic acid sequence, mutation, copy number, or methylation changes
US20230287484A1 (en) Method and markers for identification and relative quantification of nucleic acid sequence, mutation, copy number, or methylation changes using combinations of nuclease, ligation, deamination, dna repair, and polymerase reactions with carryover prevention
CN114752672B (zh) 基于循环游离DNA突变进行滤泡性淋巴瘤预后评估的检测panel、试剂盒及应用
GB2623570A (en) Method and products for biomarker identification
WO2024192294A1 (en) Methods and systems for generating sequencing libraries
CA3022606C (en) Methods of capturing cell-free methylated dna and uses of same
HK40116163A (en) Methods of capturing cell-free methylated dna and uses of same
WO2026024956A1 (en) Selecting low technical noise biomarkers for sensitive molecular diagnostics
HK40038488A (en) Methods and materials for assessing and treating cancer

Legal Events

Date Code Title Description
A107 Divisional application of patent
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 4